ATE210928T1 - Therapeutische diät für hunde mit lymphom - Google Patents

Therapeutische diät für hunde mit lymphom

Info

Publication number
ATE210928T1
ATE210928T1 AT96934026T AT96934026T ATE210928T1 AT E210928 T1 ATE210928 T1 AT E210928T1 AT 96934026 T AT96934026 T AT 96934026T AT 96934026 T AT96934026 T AT 96934026T AT E210928 T1 ATE210928 T1 AT E210928T1
Authority
AT
Austria
Prior art keywords
omega
lymphoma
dogs
dry matter
fatty acids
Prior art date
Application number
AT96934026T
Other languages
English (en)
Inventor
Gregory K Ogilvie
Deborah J Davenport
Kathy L Gross
Michael S Hand
Original Assignee
Colgate Palmolive Co
Gregory K Ogilvie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24172105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE210928(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colgate Palmolive Co, Gregory K Ogilvie filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of ATE210928T1 publication Critical patent/ATE210928T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96934026T 1995-10-10 1996-10-04 Therapeutische diät für hunde mit lymphom ATE210928T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/544,421 US5776913A (en) 1995-10-10 1995-10-10 Therapeutic diet for metabolic abnormalities found in animals with lymphoma
PCT/US1996/015865 WO1997013415A1 (en) 1995-10-10 1996-10-04 Therapeutic diet for dogs with lymphoma

Publications (1)

Publication Number Publication Date
ATE210928T1 true ATE210928T1 (de) 2002-01-15

Family

ID=24172105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934026T ATE210928T1 (de) 1995-10-10 1996-10-04 Therapeutische diät für hunde mit lymphom

Country Status (16)

Country Link
US (1) US5776913A (de)
EP (1) EP0854681B1 (de)
JP (1) JP4216334B2 (de)
AT (1) ATE210928T1 (de)
AU (1) AU707341B2 (de)
BR (1) BR9611044A (de)
CA (1) CA2234249C (de)
DE (1) DE69618218T2 (de)
DK (1) DK0854681T3 (de)
ES (1) ES2170269T3 (de)
MX (1) MXPA98002779A (de)
NO (1) NO325357B1 (de)
NZ (1) NZ319911A (de)
TR (1) TR199800744T2 (de)
WO (1) WO1997013415A1 (de)
ZA (1) ZA968482B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5891925A (en) * 1997-06-27 1999-04-06 Abbott Laboratories Diagnostic method for assessing the serum cholesterol response to low diets
US6039952A (en) * 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
AUPP887399A0 (en) * 1999-02-24 1999-03-25 Bartlett Grain Pty Ltd Animal feed formulae for the nutritional enrichment of foodstuffs
US6291496B1 (en) 1999-12-27 2001-09-18 Andrew J. Dannenberg Treating cancers associated with overexpression of class I family of receptor tyrosine kinases
US6436463B1 (en) * 2000-06-26 2002-08-20 Hill's Pet Nutrition, Inc. Pet food composition and method
JP4532822B2 (ja) * 2000-07-14 2010-08-25 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ペットの皮膚および皮を改善するための食餌性脂質
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20030138547A1 (en) * 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
ATE391514T1 (de) * 2002-01-22 2008-04-15 Mars Inc Gewichtskontrollsystem für adipöse tiere
GB0207830D0 (en) * 2002-04-04 2002-05-15 Mars Uk Ltd Animal composition
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US20060204636A1 (en) * 2002-12-23 2006-09-14 Butterwick Richard F Food for gastrointestinal health
US8034372B2 (en) * 2003-03-05 2011-10-11 Nestec, Ltd. Dietary supplement for athletic pets
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
JP2007502805A (ja) * 2003-08-18 2007-02-15 ビーティージー・インターナショナル・リミテッド 神経変性状態の処置
DK1753302T3 (da) * 2003-11-25 2011-08-15 Virginia Tech Intell Prop Sammensætning til dyrefoder og fremgangsmåde til at reducere map-kinaseaktivitet
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
EP1835817B1 (de) * 2004-12-30 2018-02-14 Hill's Pet Nutrition, Inc. Zum verzehr durch katzen bestimmte zusammensetzungen
JP5295567B2 (ja) * 2004-12-30 2013-09-18 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢期の動物の生活の質を高めるための方法
CN104068215A (zh) * 2004-12-30 2014-10-01 希尔氏宠物营养品公司 用于猫消费的基于肉类和碳水化合物的组合物的制备方法
ES2579430T3 (es) * 2004-12-30 2016-08-11 Hill's Pet Nutrition, Inc. Métodos para aumentar la calidad de vida de un animal en crecimiento
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
ES2392586T3 (es) * 2005-06-29 2012-12-12 Hill's Pet Nutrition, Inc. Métodos y composiciones para la prevención y el tratamiento de enfermedades inflamatorias
ES2275435B1 (es) * 2005-11-18 2008-06-01 Farmaleis, S.L. "composicion farmaceutica que comprende escualeno y uso de la misma para la preparacion de un medicamento para el tratamiento del cancer.
CN105211641A (zh) * 2007-12-21 2016-01-06 希尔氏宠物营养品公司 宠物食品组合物
AU2013200758B2 (en) * 2008-07-18 2014-06-12 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
NO341929B1 (no) * 2009-09-14 2018-02-19 Chemoforma Ltd Fôrsammensetning
RU2013140443A (ru) 2011-02-02 2015-03-10 Нестек С.А. Питательные композиции с высоким содержанием белка и способы их приготовления и применения
PH12014500198A1 (en) 2011-07-15 2017-02-10 Nusirt Sciences Inc Compositions and methods for modulating metabolic pathways
JP6469015B2 (ja) 2012-11-13 2019-02-13 ニューサート サイエンシーズ， インコーポレイテッド エネルギー代謝を増大させるための組成物および方法
US9585876B2 (en) 2013-03-15 2017-03-07 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
CA2903752A1 (en) * 2013-03-15 2014-09-25 Nusirt Sciences, Inc. Treatment of pets with sirtuin activators
JP2017506651A (ja) 2014-02-27 2017-03-09 ニューサート サイエンシーズ， インコーポレイテッド 脂肪肝の低減または予防のための組成物および方法
US12324797B2 (en) 2018-10-01 2025-06-10 Wintermute Biomedical, Inc. Therapeutic compositions
CN114828643A (zh) 2019-12-19 2022-07-29 希尔氏宠物营养品公司 用于治疗例如焦虑的具有特定不溶性纤维与可溶性纤维比率的组合物
EP4022090B1 (de) * 2019-12-19 2026-03-18 Hill's Pet Nutrition, Inc. Zusammensetzungen in verfahren zur verminderung der gefahr des auftretens und zur behandlung von hypothyreose bei hunden
WO2024057117A1 (en) 2022-09-14 2024-03-21 Societe Des Produits Nestle Sa Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282254A (en) * 1979-10-04 1981-08-04 General Foods Corporation Dog food of improved acceptability
JP2723243B2 (ja) * 1988-02-25 1998-03-09 サントリー株式会社 高度不飽和脂肪酸添加動物飼料
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
JPH0638708A (ja) * 1992-05-15 1994-02-15 Earth Chem Corp Ltd ナトリウム吸収阻害剤、ナトリウム吸収阻害剤を含有する高血圧予防食品、及び高血圧治療剤
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses

Also Published As

Publication number Publication date
AU7254596A (en) 1997-04-30
DE69618218T2 (de) 2002-08-22
BR9611044A (pt) 1999-12-28
CA2234249A1 (en) 1997-04-17
MXPA98002779A (es) 2003-08-08
JPH11513561A (ja) 1999-11-24
DE69618218D1 (de) 2002-01-31
CA2234249C (en) 2002-03-26
EP0854681B1 (de) 2001-12-19
NO325357B1 (no) 2008-04-07
NZ319911A (en) 1998-12-23
TR199800744T2 (xx) 1998-08-21
NO981593L (no) 1998-06-09
NO981593D0 (no) 1998-04-07
US5776913A (en) 1998-07-07
WO1997013415A1 (en) 1997-04-17
ZA968482B (en) 1998-04-08
DK0854681T3 (da) 2002-04-15
JP4216334B2 (ja) 2009-01-28
EP0854681A1 (de) 1998-07-29
AU707341B2 (en) 1999-07-08
ES2170269T3 (es) 2002-08-01

Similar Documents

Publication Publication Date Title
ATE210928T1 (de) Therapeutische diät für hunde mit lymphom
Christie The effects of diet and other factors on the lipid composition of ruminant tissues and milk
EP1392127B1 (de) Verfahren zur verbesserung des geschmacks, der zartheit und der verbraucherakzeptanz insgesamt von geflügelfleisch
Bessa et al. Reticulo-rumen biohydrogenation and the enrichment of ruminant edible products with linoleic acid conjugated isomers
Raes et al. The deposition of conjugated linoleic acids in eggs of laying hens fed diets varying in fat level and fatty acid profile
Renner et al. Utilization of fatty acids by the chicken
NZ510932A (en) Animal feed additive composition comprising at least two antimicrobial enzymes and one or more PUFAs for feeding to pigs, poultry, veal calves and fish
Whitehead The response of egg weight to the inclusion of different amounts of vegetable oil and linoleic acid in the diet of laying hens
JPH0838063A (ja) オメガ−６及びオメガ−３脂肪酸含有ペットフード製品及び炎症皮ふ反応を低減する方法
AU2002303744A1 (en) A method of improving the flavor, tenderness and overall consumer acceptability of poultry meat
Kennedy et al. Influence of dietary conjugated linoleic acid (CLA) on lipid and fatty acid composition in liver and flesh of Atlantic salmon (Salmo salar)
Afarani et al. Altering palmitic acid and stearic acid ratios in the diet of early-lactation Holsteins under heat stress: Feed intake, digestibility, feeding behavior, milk yield and composition, and plasma metabolites
Annett et al. Effects of source and level of fish oil supplementation in late pregnancy on feed intake, colostrum production and lamb output of ewes
Barlow Effects of diet on the composition of body fat in Agria affinis (Fallén)
Witter et al. The influence of the amount and nature of dietary fat on milk fat composition in the sow
Sim et al. Effect of dietary oil, cholesterol, and soysterols on the lipid concentration and fatty acid composition of egg yolk, liver and serum of laying hens
US4764532A (en) Treatment of horses
JPS5780377A (en) Ruminant animal feed improving additive
Bieri et al. Linoleic acid requirement of the chick
Baustad Cottonseed meal in the feeding of growing pigs
Gi et al. Effect of dietary Sargassum meal on growth and body composition of ayu (Plecoglossus altivelis) reared in seawater
JPS61149054A (ja) キヤツトフ−ド組成物
Herting et al. Absorption of vitamin E by the rat from a low fat diet
Or-Rashid et al. Supplemental algal-meal alters the ruminal trans-18: 1 fatty acid and CLA 3 composition in cattle
Sawosz et al. Influence of dietary lecithin and oils rich in n-3 polyunsaturated fatty acids (PUFA) on the fatty acid content of rat muscle and serum

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties